Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Endorphins are also known as “feel-good” or natural pain relievers. They are produced by the central nervous system and pituitary gland. Endorphins are released in response to stress or pain. They work similarly to a class of drugs called opioids. However, endorphins work similarly to opioid pain reliver, but their result may not dramatic. Besides, they are also released during other activities such as exercise, eating and others activities. Endorphins are also surge during pregnancy. Further, there are various medicinal herbs such as Rhodiola roseal, is known to release beta-endorphins in the brain and also used against an anti-depressant.
Global Endorphins market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Endorphins market research.
Key manufacturers engaged in the Endorphins industry include Assertio Therapeutics Inc., Cipher Pharmaceuticals Inc., Endo International Plc, Egalet Corp., Lannett Co. Inc., Pfizer and Johnson & Johnson, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Endorphins were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Endorphins market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Endorphins market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Segment by Type
Segment by Application
Consumption by Region
The Endorphins report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 Endorphins Market Overview
1.1 Product Overview and Scope of Endorphins
1.2 Endorphins Segment by Type
1.2.1 Global Endorphins Market Value Comparison by Type (2023-2029)
1.2.2 Alpha-Endorphins
1.2.3 Beta-Endorphins
1.2.4 Gamma-Endorphins
1.2.5 Sigma-Endorphins
1.3 Endorphins Segment by Application
1.3.1 Global Endorphins Market Value by Application: (2023-2029)
1.3.2 Institutional Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Endorphins Market Size Estimates and Forecasts
1.4.1 Global Endorphins Revenue 2018-2029
1.4.2 Global Endorphins Sales 2018-2029
1.4.3 Global Endorphins Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Endorphins Market Competition by Manufacturers
2.1 Global Endorphins Sales Market Share by Manufacturers (2018-2023)
2.2 Global Endorphins Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Endorphins Average Price by Manufacturers (2018-2023)
2.4 Global Endorphins Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Endorphins, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Endorphins, Product Type & Application
2.7 Endorphins Market Competitive Situation and Trends
2.7.1 Endorphins Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Endorphins Players Market Share by Revenue
2.7.3 Global Endorphins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Endorphins Retrospective Market Scenario by Region
3.1 Global Endorphins Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Endorphins Global Endorphins Sales by Region: 2018-2029
3.2.1 Global Endorphins Sales by Region: 2018-2023
3.2.2 Global Endorphins Sales by Region: 2024-2029
3.3 Global Endorphins Global Endorphins Revenue by Region: 2018-2029
3.3.1 Global Endorphins Revenue by Region: 2018-2023
3.3.2 Global Endorphins Revenue by Region: 2024-2029
3.4 North America Endorphins Market Facts & Figures by Country
3.4.1 North America Endorphins Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Endorphins Sales by Country (2018-2029)
3.4.3 North America Endorphins Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Endorphins Market Facts & Figures by Country
3.5.1 Europe Endorphins Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Endorphins Sales by Country (2018-2029)
3.5.3 Europe Endorphins Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Endorphins Market Facts & Figures by Country
3.6.1 Asia Pacific Endorphins Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Endorphins Sales by Country (2018-2029)
3.6.3 Asia Pacific Endorphins Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Endorphins Market Facts & Figures by Country
3.7.1 Latin America Endorphins Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Endorphins Sales by Country (2018-2029)
3.7.3 Latin America Endorphins Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Endorphins Market Facts & Figures by Country
3.8.1 Middle East and Africa Endorphins Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Endorphins Sales by Country (2018-2029)
3.8.3 Middle East and Africa Endorphins Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Endorphins Sales by Type (2018-2029)
4.1.1 Global Endorphins Sales by Type (2018-2023)
4.1.2 Global Endorphins Sales by Type (2024-2029)
4.1.3 Global Endorphins Sales Market Share by Type (2018-2029)
4.2 Global Endorphins Revenue by Type (2018-2029)
4.2.1 Global Endorphins Revenue by Type (2018-2023)
4.2.2 Global Endorphins Revenue by Type (2024-2029)
4.2.3 Global Endorphins Revenue Market Share by Type (2018-2029)
4.3 Global Endorphins Price by Type (2018-2029)
5 Segment by Application
5.1 Global Endorphins Sales by Application (2018-2029)
5.1.1 Global Endorphins Sales by Application (2018-2023)
5.1.2 Global Endorphins Sales by Application (2024-2029)
5.1.3 Global Endorphins Sales Market Share by Application (2018-2029)
5.2 Global Endorphins Revenue by Application (2018-2029)
5.2.1 Global Endorphins Revenue by Application (2018-2023)
5.2.2 Global Endorphins Revenue by Application (2024-2029)
5.2.3 Global Endorphins Revenue Market Share by Application (2018-2029)
5.3 Global Endorphins Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Assertio Therapeutics Inc.
6.1.1 Assertio Therapeutics Inc. Corporation Information
6.1.2 Assertio Therapeutics Inc. Description and Business Overview
6.1.3 Assertio Therapeutics Inc. Endorphins Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Assertio Therapeutics Inc. Endorphins Product Portfolio
6.1.5 Assertio Therapeutics Inc. Recent Developments/Updates
6.2 Cipher Pharmaceuticals Inc.
6.2.1 Cipher Pharmaceuticals Inc. Corporation Information
6.2.2 Cipher Pharmaceuticals Inc. Description and Business Overview
6.2.3 Cipher Pharmaceuticals Inc. Endorphins Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Cipher Pharmaceuticals Inc. Endorphins Product Portfolio
6.2.5 Cipher Pharmaceuticals Inc. Recent Developments/Updates
6.3 Endo International Plc
6.3.1 Endo International Plc Corporation Information
6.3.2 Endo International Plc Description and Business Overview
6.3.3 Endo International Plc Endorphins Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Endo International Plc Endorphins Product Portfolio
6.3.5 Endo International Plc Recent Developments/Updates
6.4 Egalet Corp.
6.4.1 Egalet Corp. Corporation Information
6.4.2 Egalet Corp. Description and Business Overview
6.4.3 Egalet Corp. Endorphins Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Egalet Corp. Endorphins Product Portfolio
6.4.5 Egalet Corp. Recent Developments/Updates
6.5 Lannett Co. Inc.
6.5.1 Lannett Co. Inc. Corporation Information
6.5.2 Lannett Co. Inc. Description and Business Overview
6.5.3 Lannett Co. Inc. Endorphins Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Lannett Co. Inc. Endorphins Product Portfolio
6.5.5 Lannett Co. Inc. Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Endorphins Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Pfizer Endorphins Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Endorphins Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Johnson & Johnson Endorphins Product Portfolio
6.7.5 Johnson & Johnson Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Endorphins Industry Chain Analysis
7.2 Endorphins Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Endorphins Production Mode & Process
7.4 Endorphins Sales and Marketing
7.4.1 Endorphins Sales Channels
7.4.2 Endorphins Distributors
7.5 Endorphins Customers
8 Endorphins Market Dynamics
8.1 Endorphins Industry Trends
8.2 Endorphins Market Drivers
8.3 Endorphins Market Challenges
8.4 Endorphins Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research